Bibliographic record

Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes

Perkovic V, Tuttle KR, Rossing P, Mahaffey KW, Mann JFE, Bakris G, Baeres FMM, Idorn T, Bosch-Traberg H, Lausvig NL, Pratley R. New England Journal of Medicine 2024

Document identifier: CEI-BR-083
Series: Bibliographic record
Version: 1.0
Published: 30 Jul 2026
Last reviewed: 30 Jul 2026
Certainty: Not rated

§1Bibliographic record

§1.1Record

Authors: Perkovic V, Tuttle KR, Rossing P, Mahaffey KW, Mann JFE, Bakris G, Baeres FMM, Idorn T, Bosch-Traberg H, Lausvig NL, Pratley R
Title: Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes
Source: New England Journal of Medicine
Year: 2024
Volume, issue, pages: 391(2):109–121
Digital object identifier: 10.1056/NEJMoa2403347
PubMed identifier: 38785209
Record type: Journal article
Institute identifier: CEI-BR-083

§1.2Institute documents citing this record

Table 1. Documents in the Institute set that cite this record.

Document	Series
Monograph: Semaglutide	Compound monograph
Trial abstract: FLOW	Trial abstract
Synthesis: Kidney outcomes with incretin receptor agonists in chronic kidney…	Evidence synthesis
3 citing documents.

§1.3Subject tags

semaglutide ckd FLOW

Compound Evidence Institute · CEI-BR-083 · https://compoundevidence.com/bibliography/perkovic2024/ · retrieved 30 July 2026